title: Iodine-131 metaiodobenzylguanidine treatment for metastatic carcinoid. Results in 98 patients.
authors.affiliation: Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.
authors.forename: Shawn D
authors.initials: SD
authors.lastname: Safford
authors.forename: R Edward
authors.initials: RE
authors.lastname: Coleman
authors.forename: Jon P
authors.initials: JP
authors.lastname: Gockerman
authors.forename: Joseph
authors.initials: J
authors.lastname: Moore
authors.forename: Jerome
authors.initials: J
authors.lastname: Feldman
authors.forename: Mark W
authors.initials: MW
authors.lastname: Onaitis
authors.forename: Douglas S
authors.initials: DS
authors.lastname: Tyler
authors.forename: John A
authors.initials: JA
authors.lastname: Olson
mesh_terms: D019797:3-Iodobenzylguanidine / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D002276:Carcinoid Tumor / Q000401:mortality / Q000532:radiotherapy* / Q000556:secondary; D005260:Female; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000652:urine; D007414:Intestinal Neoplasms / Q000532:radiotherapy*; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies
chemical_list: D007457:Iodine Radioisotopes; D019797:3-Iodobenzylguanidine; D006897:Hydroxyindoleacetic Acid